Milestones in history of adult vaccination in Korea

M Oh, JK Lee - Clinical and experimental vaccine research, 2012 - synapse.koreamed.org
Vaccination is one of the most effective and cost-benefit interventions that reduced the
mortality. Major vaccine preventable diseases have decreased dramatically after the …

[HTML][HTML] A review of factors affecting vaccine preventable disease in Japan

N Kuwabara, MSL Ching - Hawai'i Journal of Medicine & Public …, 2014 - ncbi.nlm.nih.gov
Japan is well known as a country with a strong health record. However its incidence rates of
vaccine preventable diseases (VPD) such as hepatitis B, measles, mumps, rubella, and …

[HTML][HTML] Moral dilemma (s) in human papillomavirus vaccination–revisiting the role of the herd effect

M Lehtinen, VN Pimenoff - Eurosurveillance, 2021 - eurosurveillance.org
In this Eurosurveillance issue, two articles by Colzani et al.[1] and Ortu et al.[2], raise the
question of who should be prioritised in vaccination policy when there is a temporary global …

[HTML][HTML] Disparities among Japanese municipalities in recommendations for routine and catch‐up HPV vaccinations

Y Watanabe, Y Ueda, A Yagi, S Ikeda, E Oka… - Cancer …, 2023 - ncbi.nlm.nih.gov
In November 2021, the government of Japan announced a reversal of its decision in 2013 to
suspend the previous proactive recommendation for HPV vaccination. However, the …

Stopping the HPV vaccine crisis in Japan: quantifying the benefits and risks of HPV vaccination in quality-adjusted life-years for appropriate decision-making

T Kitano - Journal of Infection and Chemotherapy, 2020 - Elsevier
Background The human papilloma virus (HPV) vaccination coverage rate in Japan has
dropped dramatically from more than 70% to less than 1% since 2013. With conflicting …

Changes in the Epidemiology of Rubella: The Influence of Vaccine-Introducing Methods and COVID-19

N Otani, M Shima, T Ueda, K Nakajima, Y Takesue… - Vaccines, 2023 - mdpi.com
Rubella is an infectious disease caused by the rubella virus. Congenital rubella syndrome is
a risk for all newborns if pregnant women are infected with rubella, raising an important …

An opportunity to increase human papillomavirus vaccination rates: Change the guidelines

A Aragones, F Gany, A Kaplan… - Human Vaccines & …, 2022 - Taylor & Francis
Given the low rates of Human Papillomavirus (HPV) vaccination initiation and timely series
completion in 11-and 12-year old children, we sought to assess potential opportunities for …

An ethics of HPV vaccination: beyond principlism

HC Stoeklé, S Sekkate, JM Ayoubi… - Human Vaccines & …, 2022 - Taylor & Francis
Healy et al. rightly raise the question of the role of medical ethics in the face of an absence of
vaccination or insufficient vaccination coverage against human papillomavirus (HPV), as …

HPV vaccination: waiting for evidence of effectiveness

EJ Suba, SS Raab - The Lancet, 2010 - thelancet.com
On Dec 1, 2009, the US Department of Health and Human Services (DHHS) issued updated
guidelines for treatment of HIV infection, 1 which include the state ment that “the Panel …

Vaccination against HPV: Easier said than done?

HC Stoeklé, S Sekkate, JM Ayoubi… - Human Vaccines & …, 2023 - Taylor & Francis
This letter is a follow-up to the one we published in Human Vaccines & Immunotherapeutics
1 in light of current events. Indeed, very recently, Bruni et al published in the Lancet Global …